0001179110-19-009746.txt : 20190821
0001179110-19-009746.hdr.sgml : 20190821
20190821161744
ACCESSION NUMBER: 0001179110-19-009746
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190819
FILED AS OF DATE: 20190821
DATE AS OF CHANGE: 20190821
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Albers Jeffrey W.
CENTRAL INDEX KEY: 0001638474
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37359
FILM NUMBER: 191043273
MAIL ADDRESS:
STREET 1: BLUEPRINT MEDICINES CORP.
STREET 2: 215 FIRST STREET, SUITE 340/350
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Blueprint Medicines Corp
CENTRAL INDEX KEY: 0001597264
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 45 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-374-7580
MAIL ADDRESS:
STREET 1: 45 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
edgar.xml
FORM 4 -
X0306
4
2019-08-19
0
0001597264
Blueprint Medicines Corp
BPMC
0001638474
Albers Jeffrey W.
C/O BLUEPRINT MEDICINES CORPORATION
45 SIDNEY STREET
CAMBRIDGE
MA
02139
1
1
0
0
CEO and President
Common Stock
2019-08-19
4
M
0
20000
1.87
A
48961
D
Common Stock
2019-08-19
4
S
0
100
85.56
D
48861
D
Common Stock
2019-08-19
4
S
0
800
84.42
D
48061
D
Common Stock
2019-08-19
4
S
0
300
82.85
D
47761
D
Common Stock
2019-08-19
4
S
0
6634
82.04
D
41127
D
Common Stock
2019-08-19
4
S
0
12166
81.33
D
28961
D
Stock Option (Right to Buy)
1.87
2019-08-19
4
M
0
20000
0
D
2024-07-30
Common Stock
20000
18080
D
Effected pursuant to a trading plan adopted on December 11, 2018 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.365 to $84.455 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (5) to this Form 4.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $ $82.79 to $82.93 per share.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $ $81.71 to $82.66 per share.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $ $80.71 to $81.695 per share.
This option was granted on July 30, 2014. This option vested as follows: (i) 42,845 shares vested in four installments at a rate of 6,974 shares on September 21, 2016, and 11,957 shares on each of October 21, 2016 and November 21, 2016, and 11,957 on December 21, 2016; (ii) 90,010 shares vested in eight installments at a rate of 6,311 shares on May 21, 2017 and 11,957 shares on each of June 21, 2017, July 21, 2017, August 21, 2017, September 21, 2017, October 21, 2017, November 21, 2017 and December 21, 2017; and (iii) 30,225 shares vested in three installments at a rate of 6,311 shares on May 21, 2018, 11,957 shares on June 21, 2018 and 11,957 shares on July 21, 2018.
/s/ Christopher Frankenfield, Attorney-in-Fact
2019-08-21